Quintiles designates Comprehensive with Prime Site status

Wednesday, September 26, 2012 09:58 AM

CRO Quintiles has designated Comprehensive Clinical Development, a Miramar, Fla.-based clinical research company, as a Quintiles Prime Site—a distinction that gives Comprehensive an enhanced role in global clinical research and testing of new and more effective medicines.

As a Quintiles Prime Site, Comprehensive has access to new industry-sponsored clinical trials through Quintiles. Comprehensive joins a group of sites across North and South America, Europe, Africa and Asia, and is the first non-academic, non-hospital based organization awarded this status.

"Comprehensive’s dedication to timeliness and quality, combined with their strong patient relationships and delivery quality, will enhance our ability to recruit patients quickly and efficiently to provide greater value for our customers,” said Lindy Jones, senior vice president, integrated site services, Quintiles. “We look forward to a successful relationship with Comprehensive.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs